Home/Filings/4/0001562180-19-002450
4//SEC Filing

Malone Daniel 4

Accession 0001562180-19-002450

CIK 0000105770other

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 10:21 AM ET

Size

8.8 KB

Accession

0001562180-19-002450

Insider Transaction Report

Form 4
Period: 2019-04-30
Malone Daniel
Vice President & Controller
Transactions
  • Sale

    Common Stock

    2019-04-30$123.03/sh4,458$548,47729,020.393 total
  • Exercise/Conversion

    Common Stock

    2019-04-30$21.34/sh+4,458$95,13433,478.393 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2019-04-304,4585,000 total
    Exercise: $21.34From: 2011-03-22Exp: 2020-03-22Common Stock (4,458 underlying)
Footnotes (1)
  • [F1]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $123.00 to $123.07, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1
  • filerCIK 0001527326

Filing Metadata

Form type
4
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 10:21 AM ET
Size
8.8 KB